NCT02918968 Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer Status COMPLETED Phase PHASE4
NCT02915523 Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02912650 A Safety And Efficacy Study of Ibuprofen 250 mg / Acetaminophen 500 mg In The Treatment Of Post-Surgical Dental Pain Status COMPLETED Phase PHASE3
NCT02912572 Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02907918 Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer Status TERMINATED Phase PHASE2
NCT02907619 An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy Status TERMINATED Phase PHASE2
NCT02906696 Bosutinib in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase After Frontline TKI Failure Status TERMINATED Phase PHASE2
NCT02905318 Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02897375 Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02896335 Palbociclib and Pembrolizumab In Central Nervous System Metastases Status RECRUITING Phase PHASE2
NCT02894398 Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or Fulvestrant Status COMPLETED Phase PHASE2
NCT02890368 Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides Status TERMINATED Phase PHASE1
NCT02888938 Diagnosis of Structural Sacroiliitis in Patients With Suspicion of Spondyloarthritis (EchoSPA) Status UNKNOWN Phase N/A
NCT02883114 An Open-Label, 2 Treatment Period,Study To Study The Drug Interaction Between Repeated Doses Of Itraconazole And Single Dose Pharmacokinetics (PK) Of PF-06648671 In Healthy Adults. Status COMPLETED Phase PHASE1
NCT02880371 A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT02879747 Individualizing Dose of Growth Hormone to Maintain Normal Growth Velocity After Fulfilled Catch up Growth in Children Status COMPLETED Phase PHASE2/PHASE3
NCT02878785 Decitabine and Talazoparib in Untreated AML and R/R AML Status COMPLETED Phase PHASE1/PHASE2
NCT02871037 Single Dose, Repeated Dose, and Conditional Food Effect Study of PF-05221304 in Healthy Subjects Status COMPLETED Phase PHASE1